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ABSTRACT

The invention provides Bean pod mottle virus (BPMV) vec

tors useful for expression of heterologous proteins in plants
such as soybean. The BPMV vectors are also useful for virus

induced gene silencing. The invention also provides methods
for expressing a heterologous polypeptide in a plant such as

soybean. The invention additionally provides methods for
virus-induced gene silencing, particularly in a soybean plant,
Which can be used to determine the function of a gene of
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VIRAL VECTORS USEFUL IN SOYBEAN AND
METHODS OF USE

ods for virus-induced gene silencing, particularly in a soy
bean plant, Which can be used to determine the function of a
gene of interest.

BACKGROUND OF THE INVENTION

BRIEF DESCRIPTION OF THE DRAWINGS

This invention relates generally to the area of plant molecu

The patent or application ?le contains at least one draWing

lar biology and more speci?cally to plant viral expression

executed in color. Copies of this patent or patent application

vectors.

publication With color draWings Will be provided by the
O?ice upon request and payment of the necessary fee.
FIGS. 1A-1C shoWs a schematic representation of BPMV
RNA2 vector constructs. FIG. 1A shoWs the genome organi
Zation of BPMV RNA2 and vector construction strategy.
RNA2 is translated into tWo overlapping carboxy coterminal

Plant virus-based vectors for expressing heterologous pro

teins in plants present promising biotechnological tools to
supplement conventional breeding and transgenic technol
ogy. Considering the speed With Which a virus infection

becomes established throughout the plant and the high yield

polyproteins. CR, RNA2 replication cofactor; MP, movement
protein; L-CP, large coat protein; S-CP, small coat protein. A
foreign gene (GFP) is inserted betWeen MP and L-CP coding
sequences. The cleavage site (QM; boxed) is duplicated With

of viral-encoded proteins that accumulate in plants, the use of
viral vectors provides an attractive and cost effective means

for the overproduction of valuable proteins in plants and for
rapid evaluation of neW traits.

Several different types of positive sense RNA plant viruses
have been developed as vectors for production of recombi

nant proteins and peptides (Pogue et al., Annu. Rev. Phylo
palhol. 40:45-74 (2002); Scholthof et al., Annu. Rev. Phylo
palhol. 341299-323 (1996)). Depending on the structure of

20

the 8 C-terminal amino acids of the MP and the 19 N-terminal
amino acids of the L-CP included for e?icient processing.

Amino acids, in the one-letter code, (SEQ ID NO: 1), are
indicated above the nucleotide sequences (SEQ ID NO: 26,
SEQ ID NO: 27 and SEQ ID NO: 28). Altered nucleotides are
25

the viruses involved and their genome replication and expres
sion strategies, a number of approaches including gene

printed in red in loWercase. The GFP gene is shoWn as a green
box. The introduced restriction sites, SWaI and AatII, are
boxed. FIG. 1B shoWs a schematic presentation of BPMV
RNA2 vector constructs. The upper sequence shoWs con

replacement, gene insertion, epitope presentation, and

struct pGG7R2 -GFP With GFP inserted betWeen tWo arti?cial

complementation have been utiliZed. Plant viral vectors are

proteolytic cleavage sites; the designation G7R2 indicates

presently available for recombinant protein expression in a
Wide range of host plants including Nicoliana benlhamiana,

30

version of construct pGG7R2-GFP, contains additional
restriction sites for cloning of foreign genes. A foreign gene

tobacco, squash, cucumber, Wheat, barley, coWpea, Nicoliana

clevelandii, Chenopodium quinoa, andArabidopsis (Allison
et al., .1. Wrol. 6213581-3588 (1998); Brisson et al., Nature

35

3101511-514 (1984); Choi etal.,Planz.1. 231547-555 (2000);
Constantin et al., Plant .1. 401622-631 (2004); Dolja et al.,
Proc. Natl. Acad. Sci. USA. 89110208-10212 (1992);
FemandeZ-FemandeZ et al., Wrology 2801283-291 (2001);
French et al., Science 23111294-1297 (1986); Gopinath et al.,
Wrology 2671159-173 (2000); HagiWara et al., .1. Virol.
7317988-7993 (1999); Haupt et al., Plant Physiol. 1251209
218 (2001); Lacomme et al., Plant .1. 341543-553 (2003);
Tumage et al., Plant .1. 301107-117 (2002)). Even With these
advances, there are only a limited number of plant viral vec

matic representation of the proteins expressed from the
BPMV RNA2 vector listed in increasing order of their sizes:
40

tease protein.
45

FIGS. 2A-2D shoWs green ?uorescence on inoculated and

systemic leaves of soybean plants. Soybean seedlings Were
inoculated on their primary leaves With leaf extracts prepared
from plants infected With the BPMV-GFP construct after four

serial passages in soybean. Alternatively, the primary leaves
50

involving expression of valuable proteins that confer disease/

Were inoculated With the Wild-type K-Hol isolate or mock

inoculated With buffer only. The primary leaf (FIG. 2A) and
second trifoliolate leaf (FIG. 2B) from a soybean plant, pre

pest resistance and/or those that enhance the commercial

value of soybean.
Thus, there exists a need for reagents useful for expressing
55

viously inoculated With the BPMV-GFP construct, shoWed
intense green ?uorescence under UV light. No ?uorescence
Was detected on the mock-inoculated primary leaf (FIG. 2C)
or on the second trifoliolate of K-Hol -infected plants (FIG.

2D). Leaves in FIGS. 2A, 2B, and 2D shoWed symptoms

satis?es these needs and provide related advantages as Well.

typical of isolate K-Hol; mosaic and necrosis on inoculated
leaves and mottling on systemic leaves. All leaves Were pho

SUMMARY OF INVENTION
60

tographed under UV light 11 days postinoculation.
FIGS. 3A-3B shoWs immunoblot analysis of total proteins
from soybean plants infected With GFP constructs. FIG. 3A
shoWs Western blot analysis using an anti-GFP antiserum.

The invention provides Bean pod mottle virus (BPMV)
vectors useful for expression of heterologous proteins in
plants such as soybean. The BPMV vectors are also useful for

virus-induced gene silencing. The invention also provides
methods for expressing a heterologous polypeptide in a plant
such as soybean. The invention additionally provides meth

P19, Tomato bushy stunt virus P19 protein; Bar, phosphino
thricin acetyltransferase; DsRed, DsRed red ?uorescent pro

tein; GFP, green ?uorescent protein; TCVCP, Turnip crinkle
virus coat protein; HCPro, potyvirus helper component-pro

oil and high-quality protein WorldWide, and there is critical

heterologous proteins in plants such as soybean and deter
mining the function of plant genes. The present invention

can be cloned as a BamHI-MscI fragment in the pGG7R2-V
vector after the vector is digested With same tWo enZymes.

Alternatively, the foreign gene can be blunt-end ligated into
MscI-digested pGG7R2-V vector. FIG. 1C shoWs a diagram

tors that are suitable for systemic expression of foreign pro
teins in major crops like soybean. Soybean is a main source of
need for tools that alloW for rapid evaluation of neW traits

that RNA2 Was derived from BPMV strain G7. The loWer
sequence shoWs construct pGG7R2-V, Which is a modi?ed

Samples of total proteins (15 pg) extracted from soybean
65

plants subjected to the folloWing treatments were used: mock

inoculated (1st trifoliolate; lane 1), Wild-type BPMV K-G7
infected (1 st trifoliolate; lane 2), pGG7R2-GFP-infected (1st

US 7,618,815 B2
3
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and 2nd trifoliolate leaves; lanes 3 and 4, respectively), and
pGHoR2-GFP-infected (1 st and 2nd trifoliolate leaves; lanes

vectors of the invention are useful for e?icient expression of

5 and 6, respectively). Puri?ed His6-tagged GFP protein (50

vectors are also useful for virus-induced gene silencing. The

ng) Was included in lane 7. Lane M contains loW molecular

invention also provides methods for expressing a heterolo
gous polypeptide in a plant such as soybean. The present
invention provides the ?rst plant-virus-based vector that is

heterologous proteins in plants such as soybean. The BPMV

Weight protein markers. In FIG. 3B, levels of protein loading
Were assessed by SDS-PAGE analysis and Coomassie blue
staining of the proteins tested in FIG. 3A.
FIGS. 4A-4C shoWs the stability of the GFP and DsRed
genes expressed from the BPMV vectors. FIGS. 4A and 4B
shoW Northern blot hybridization analysis to assess the sta

appropriate for expression of forei gn proteins in soybean. The
invention additionally provides methods for virus-induced
gene silencing, particularly in a soybean plant, Which can be
used to determine the function of a gene of interest. The

bility of foreign gene inserts. RNA extracted from puri?ed
virions from soybean plants previously inoculated With the
folloWing virus isolates or transcripts Were used: 1, Wild-type

BPMV vectors of the invention advantageously alloW e?i

cient systemic expression of foreign polypeptides and nucleic
acids in soybean.

strain K-Hol; 2, Wild-type strain K-G7; 3, pGHoRl+

BPMV is a member of the genus Comovirus in the family

pGG7R2-GFP transcripts; 4, pGHoRl+pGG7R2-DsRed
transcripts; 5, pGHoRl+pGHoR2-GFP transcripts; and 6,

Comoviridae (Lomonossoff and Ghabrial, Encyclopedia of
Plant Pathology, Vol. 1 (2001)). BPMV has a bipartite posi
tive-strand RNA genome consisting of RNA1 (approximately
6.0 kb) and RNA2 (approximately 3.6 kb) that are separately

pGHoRl +pGHoR2-DsRed transcripts. In FIG. 4A, a probe
speci?c for K-Hol RNA2 (type II) Was used. In FIG. 4B, a
probe speci?c for K-G7 RNA2 (type I) Was used. Note that
the recombinant RNA2 constructs containing GFP or DsRed

encapsidated in isometric particles 28 nm in diameter. TWo
20

distinct subgroups of BPMV strains, designated subgroups I
and II, have been previously isolated and extensively charac
teriZed (Gu et al., Phylopalhology 92:446-452 (2002); Gu et
al., Wrology 333:271-283 (2005)). The BPMV genome is
expressed via the synthesis and subsequent proteolytic pro

25

cessing of polyprotein precursors. BPMV RNA-1 codes for
?ve mature proteins required for replication, Whereas RNA-2
codes for a putative cell-to-cell movement protein (MP) and
the tWo coat proteins (L-CP and SCP). As disclosed herein,
stable BPMV-based vectors can be generated by inserting the

(lanes 3-6) are larger in siZe than those of the Wild-type RNA2
(lanes 1 and 2). In FIG. 4C, levels of RNA loading Were
assessed by ethidium bromide staining of viral RNA.
FIG. 5 shoWs herbicide resistance in soybean conferred by
infection With the BPMV vector expressing the bar gene.
Soybean seedlings Were inoculated onto the primary leaves

With either Wild-type virus, transcripts from the BPMV-bar
construct, transcripts from the BPMV-GFP construct, or
mock-inoculated With buffer alone. The herbicide treatment

(0.1% amino glufosinate in deioniZed Water) Was applied to
all plants When the second trifoliolate leaves Were fully

30

gene of interest into the RNA2-encoded polyprotein open

expanded. Photographs Were taken 20 days after the herbicide

reading frame, betWeen the MP and L-CP coding regions, and
constructing additional proteinase cleavage sites to ?ank the

treatment. Soybean plants infected With: BPMV-bar con

foreign protein.
Plant virus-based vectors provide valuable tools for

struct (FIG. 5A); mock-inoculated control (FIG. 5B); Wild
type BPMV strain K-G7 (FIG. 5C); and BPMV-GFP con
struct (FIG. 5D) are shoWn.
FIG. 6 shoWs enhancement of symptom severity in soy
bean plants infected With the BPMV vector carrying knoWn
viral suppressors of RNA silencing. Photographs of ?rst tri
foliolate leaves from soybean plants inoculated With leaf

35

expression of foreign proteins in plants and for gene function
studies. None of the previously available virus vectors is
suitable for use in soybean. As disclosed herein, Bean pod
mottle virus (BPMV)-based vectors are useful for gene

expression and virus-induced gene silencing (VIGS) in plants
40

such as soybean. The genes of interest Were inserted into the

extracts from plants infected With transcripts from pGHoRl

RNA2-encoded polyprotein open reading frame betWeen the

plus transcripts from: pGG7R2 (panel 2); pGG7R2-P19
(panel 3); pGG7R2-TCVCP (panel 4); pGG7R2-HCPro(S7)

movement protein (MP) and the large coat protein (L-CP)
coding regions. Additional proteinase cleavage sites Were
created to ?ank the foreign protein by duplicating the MP/L

(panel 5); or pGG7R2-HCPro(T) (panel 6) are shoWn. A
mock-inoculated control plant is shoWn in panel 1. Note
enhanced symptom severity including necrosis on soybean
plants infected With BPMV constructs carrying suppressors
of RNA silencing (panels 3-6). The photographs Were taken 2

45

ing amino acid sequences. The recombinant BPMV con
structs Were stable folloWing several serial passages in soy

Weeks postinoculation.
FIG. 7 shoWs virus-induced gene silencing (VIGS) of the
soybean PDS gene. FIGS. 7A and 7B shoW phenotypes of
soybean plants 21 days postinoculation With the BPMV vec
tor carrying a fragment of the soybean PDS gene (pGG7R2

50

ferent biological activities Was demonstrated from the BPMV

pho sphinothricin acetyltransferase (encoded by the herbicide
55

soybean plants previously inoculated With the pGG7R2-PDS

resistance bar gene), and the RNA silencing suppressors

encoded by Tomato bushy stunt virus, Turnip crinkle virus,
Tobacco etch virus, and Soybean mosaic virus. The possible

vector shoWing different degrees of photobleaching are
shoWn. FIG. 7G shoWs soybean plant previously inoculated

use of BPMV as a VIGS vector to study gene function in

With the vector control pGG7R2 shoWing typical mottling
symptoms and no bleaching. FIG. 7H shoWs mock-inocu

bean and relatively high levels of protein expression Were
attained. Successful expression of several proteins With dif
vector. These included the reporter proteins GFP and DsRed,

PDS) and empty vector control (pGG7R2), respectively.
FIGS. 7C-7F shoW representative 3rd trifoliolate leaves from

CP cleavage site. To minimize the chances of homologous
recombination and thus insert instability, the nucleotide
sequence of the duplicated regions Was altered Without affect

60

soybean Was also demonstrated With the phytoene desaturase
gene. The results disclosed herein indicate that the BPMV

lated soybean plant. The photographs Were taken 21 days

based vectors are suitable for expression of foreign proteins in

postinoculation.

soybean and for functional genomics applications.

DETAILED DESCRIPTION OF THE INVENTION
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The present invention provides Bean pod mottle virus
(BPMV) vectors useful inplants such as soybean. The BPMV

In one embodiment, the invention provides a Bean pod
mottle virus (BPMV) vector containing a nucleic acid
sequence encoding an RNA2 polyprotein open reading frame
(ORF), Wherein the RNA2 polyprotein ORF comprises a ?rst
and second protease cleavage site such as a QM cleavage site,

5

6

wherein the nucleic acid sequences encoding the ?rst and
second protease cleavage site such as a QM cleavage sites
differ suf?ciently to reduce homologous recombination

DVETPKGS (SEQ ID NO: 1). Although exempli?ed With this
particular sequence, it is understood by those skilled in the art
that shorter or longer ?anking sequences can be used, or even
modi?cations of these sequences, so long as a suf?cient

betWeen the QM cleavage site encoding nucleic acid

cleavage ef?ciency is achieved suitable for a particular appli

sequences. The protease cleavage site such as a QM cleavage
sites can be located, for example, betWeen the movement

cation of the BPMV vectors of the invention. One skilled in
the art can readily determine a su?icient cleavage e?iciency,

protein (MP) and large coat protein (L-CP) encoded by the

for example, by determining the e?iciency of production of
BPMV, Which requires su?icient processing and cleavage of

RNA2 polyprotein. The vector can contain restriction sites for
insertion of a heterologous sequence betWeen the QM cleav
age sites.
As used herein, a “Bean pod mottle virus vector” or

the RNA2 polyprotein to propagate virus. Although exempli
?ed herein using a QM cleavage site, it is understood by those
skilled in the art that the invention can also be practiced using
other protease cleavage sites so long as suf?cient processing

“BPMV vector” refers to a nucleic acid vector that, on its oWn

or in combination With other nucleic acids, is capable of
generating BPMV When expressed in a host cell or organism.

occurs so that BPMV is produced and is capable of propaga
tion.
Although exempli?ed herein as inserting a nucleic acid

A BPMV vector can be, for example, a BPMV genome such
as a genome contained in a Whole virus. In addition, a BPMV
vector can be a plasmid encoding a portion of a BPMV

encoding a heterologous polypeptide betWeen the movement

protein (MP) and large coat protein (L-CP) of BPMV RNA2,

genome. For example, as disclosed herein, a plasmid encod
ing one of the tWo RNAs that comprise the BPMV genome

it is understood that a heterologous polypeptide can be

can be used as a BPMV vector that, When combined With a 20 inserted in other locations on RNA2, for example, betWeen
other encoded BPMV proteins, or on RNAl so long as BPMV
second plasmid that contains the other RNA, results in the

production of BPMV virus (see Examples).

is produced and is capable of propagation. For example, a
heterologous sequence can be inserted doWnstream from the

As used herein, an “RNA2 polyprotein” refers to the open

reading frame encoded by an approximately 3.6 kb RNA,
designated RNA2, found in BPMV, as previously described
(see Gu et al.,. Phylopalhology 92:446-452 (2002; Gu and
Ghabrial, Wrology 333:271-283 (2005)). A schematic repre
sentation of the genome organization of BPMV RNA2 is
shoWn in FIG. 1A.
As used herein, a “protease cleavage site” refers to an
amino acid sequence recogniZed and cleaved by a site-spe

25

small coat protein (S-CP) sequence of RNA2 With the engi
neering of an appropriate protease cleavage site. BPMV
RNA2 is about 3.6 kb, and BPMV RNAl is about 6 kb.
BPMV RNAl and RNA2 are separately packaged in identical
capsids, 28 nm in diameter, and the maximum siZe that can be
packaged in BPMV viral capsids is about 6 kb. Therefore, a

30

heterologous sequence up to about 2.4 kb can be accommo

ci?c protease, for example, a virally-encoded site-speci?c

dated in a viral capsid encapsidating BPMV RNA2, although
the e?iciency of expression of larger sequences may be

protease. Site-speci?c proteases are Well knoWn in the art. In

reduced. It is also possible to express more than one heter

ologous sequence, again With appropriate protease sequences

the case Where an expression vector such as a BPMV vector of

the invention is to be used in a host plant such as soybean, it

35

is understood that the site-speci?c protease cleavage sites
should be recogniZed by a site-speci?c protease, for example,

MP and the L-CP, or one heterologous sequence can be

located betWeen the MP and the L-CP and the other after the

a site-speci?c protease encoded by BPMV RNAl, as dis
closed herein. For example, in BPMV, the tWo RNA viral
genomes express polyprotein precursors, Which are pro

engineered. TWo heterologous sequences can either be
inserted at the same location, for example both betWeen the

S-CP, With appropriately engineered protease cleavage sites.
40

If more than one heterologous sequence is included in BPMV

cessed post-translationally to produce mature proteins. Thus,

RNA2, together the total siZe of all heterologous sequences

appropriate proteases are expressed that alloW proper pro
cessing of the polyprotein to mature proteins. An example of
such a protease cleavage site is the site betWeen the movement

included in a single BPMV RNA2 construct should not
exceed about 2.4 kb in siZe since this Would exceed the

protein (MP) and large coat protein (L-CP) of the RNA2
polyprotein (see FIG. 1). Such a site is cleaved at GlnMet
betWeen MP and L-CP and is exemplary of a “QM cleavage
site.”
As used herein, a “QM cleavage site” refers to a protease
cleavage site containing GlnMet. An example of such a cleav
age site is the GlnMet sequence that is the cleavage site

capacity of the viral capsid. Alternatively, a second or addi
45

expressed. If the same protease cleavage site is engineered to
50

can be modi?ed to minimiZe homologous recombination, as
disclosed herein.
In addition to using a BPMV RNA2 vector, it is possible
55

heterologous sequence by appropriate engineering of restric
described for RNA2. RNAl contains the coding regions of

?ve proteins: from the 5'-nd proteaase-cofactor (Co-pro),

e?icient processing and cleavage of the QM cleavage site.
60

cleavage site, for example, a QM cleavage site ?anked by 8
amino acids derived from the C-terminus of the MP and 19
amino acids derived from the N-terminus of the L-CP (see

FIG. 1A).
In a particular embodiment, a QM cleavage site can contain
the amino acid sequence QYNEVQAQMETNLFKLSLD

that a BPMV RNAl based vector could be used to express a

tion sites for insertion of heterologous sequences, as

N-terminal amino acids of L-CP can be included to increase

Thus, a QM cleavage site can be a naturally occurring or
arti?cial site engineered to generate a site-speci?c protease

effect cleavage of more than one heterologous sequence, the

nucleic acid sequence encoding the protease cleavage site(s)

betWeen the movement protein (MP) and large coat protein
(L-CP) of the BPMV RNA2 polyprotein (see FIG. 1A). A QM
cleavage site can include additional ?anking sequences, for
example, from MP and L-CP, to increase ef?cient cleavage of
the QM cleavage site. In a particular embodiment disclosed
herein, the 8 C-terminal amino acids of the MP and the 19

tional heterologous sequence can be expressed on a separate
RNA2 vector, and ?rst and second RNA2 vectors, each
expressing at least one different heterologous sequence, can
be co-infected so that more than one heterologous sequence is

65

helicase (Hel), VPg, protease (Pro) and RNA-dependent
RNA polymerase (RdRp). The intermediate polyproteins
Hel+VPg and Pro+RdRp play important roles in replication.
The cleavage site betWeen Co-pro and Hel, Which is
glutaminezalanine (QA), is an exemplary site for inserting a
heterologous sequence. HoWever, since the RNAl vector is
about 6 kb and the capsid siZe limit is about 6 kb, it is likely
that only small heterologous sequences can be accommo

7

8

dated in an RNAl-based vector. One skilled in the art can

nucleic acid sequence encoding a heterologous polypeptide
inserted betWeen the ?rst and second QM cleavage sites, for
example, betWeen BCMV movement protein (MP) and large

readily determine appropriate protease cleavage sites, clon
ing sites and siZes of heterologous sequences suitable for
expression from an RNAl -based vector by making such
constructs and inoculating an appropriate plant host such as
soybean and testing for e?icient BPMV infection. An RNAl

coat protein (L-CP).
As disclosed herein and exempli?ed in FIG. 1, a BPMV
vector can be modi?ed to include cloning sites for conve

nience of introducing a heterologous nucleic acid into the
vector. It is understood that suitable restriction sites, includ
ing those disclosed herein and shoWn in FIG. 1 as Well as

-based vector With an inappropriate insert of a heterologous
sequence can be readily determined since such a vector Would

result in poor if any BPMV production and, conversely, an
appropriate insert of a heterologous sequence can be deter
mined based on su?icient BPMV production.
As used herein, the phrase “differ suf?ciently to reduce
homologous recombination,” refers to a difference in homol

other restriction sites, can be included in a BPMV vector of
the invention, as desired.

As used herein, the term “heterologous,” When used in
reference to a polypeptide, nucleic acid or gene, refers to a

polypeptide, nucleic acid or gene that is not naturally
expressed, for example, by a BPMV or host organism. In

ogy betWeen tWo nucleic acid sequences such that the amount

of homologous recombination betWeen the sequences is
reduced. For example, in an embodiment of the invention in
Which a protease cleavage site such as a QM cleavage site is
present as tWo copies, the nucleic acid sequences encoding
the protease cleavage sites can be similar or identical if the
protease cleavage sites are similar or identical. In such a case,

reference to a BPMV vector, heterologous refers to a

20

the homology betWeen the nucleic acid sequences encoding
the protease cleavage site can undergo homologous recombi
nation. In the case Where a nucleic acid encoding a heterolo

gous polypeptide is inserted betWeen the protease cleavage
sites, homologous recombination Would result in loss of the
heterologous sequence and therefore decreased expression of
the heterologous polypeptide. To minimiZe the chance of
recombination, the nucleic acid sequences encoding the tWo
copies of the protease cleavage site can be modi?ed based on
the degeneracy of the genetic code such that the same amino
acids are encoded. For example, FIG. 1 shoWs a particular
embodiment in Which the third nucleotide of each codon is
changed in one copy of a QM cleavage site so that the encoded
amino acids remain the same. Although exempli?ed With one
of the nucleic acid sequences encoding one of the protease
cleavage sites being modi?ed, it is understoodthat one orboth
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polypeptide, nucleic acid or gene that is not naturally
expressed by a BPMV.
The invention also provides a method for expressing a
heterologous polypeptide in a plant such as a soybean plant.
The method can include the step of inoculating a soybean
plant With Bean pod mottle virus (BPMV) RNAl and recom
binant RNA2, Wherein the recombinant BPMV RNA2 com
prises a nucleic acid sequence encoding an RNA2 polyprotein

open reading frame (ORF), Wherein the RNA2 polyprotein
ORF comprises a ?rst and second protease cleavage site such
as a QM cleavage site, Wherein the nucleic acid sequences
encoding the ?rst and second protease cleavage site such as a

QM cleavage site differ suf?ciently to reduce homologous
30

recombination betWeen the protease cleavage site, such as a

QM cleavage site, encoding nucleic acid sequences and
Wherein a nucleic acid sequence encoding a heterologous
polypeptide is inserted betWeen the ?rst and second protease
cleavage sites such as QM cleavage sites. In a particular
35

embodiment, the method can be performed With a vector in

Which the ?rst QM cleavage sites are located betWeen the

sequences can be modi?ed so long as there is a suf?cient

movement protein (MP) and large coat protein (L-CP)

difference in homology to reduce homologous recombination
betWeen the sequences. For example, instead of modifying
one copy, it is possible to modify both nucleic acids, for

encoded by the RNA2 polyprotein. The recombinant RNA2
can contain restriction sites for inserting the nucleic acid
40

example, by alternating modi?ed codons in the tWo copies,
Which Would similarly result in reduced homology betWeen
the tWo sequences and therefore reduce homologous recom
bination. One skilled in the art can readily determine a differ

ence in homology suf?cient to reduce homologous recombi

method can be used, for example, to produce large quantities
45

nation, for example, by using vectors of the invention,
inoculating a suitable host plant such as soybean and deter
mining the amount of homologous recombination that has
occurred. If homologous recombination has occurred at a
level that makes a particular BPMV vector unsuitable for a
particular use, one skilled in the art can make further changes
in homologous sequences in order to reduce the amount of
recombination that occurs. Furthermore, although FIG. 1
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Thus, in a particular embodiment, the invention provides a
vector in Which each codon encoding the QM cleavage site
differs betWeen the nucleic acid sequences encoding the ?rst
QM cleavage site and the second QM cleavage site. In one
embodiment, one of the QM cleavage sites can comprise the
amino acid sequence QYNEVQAQMETNLFKLSLDDVET
PKGS (SEQ ID NOzl). In another embodiment, the amino
acid sequences of the ?rst and second QM cleavage sites are
identical, and can be, for example, the amino acid sequence

QYNEVQAQMETNLFKLSLDDVETPKGS

(SEQ

ID

NO: 1). In still another embodiment, the vector can contain a

of a polypeptide of interest. Production of such heterologous
polypeptides can be used to produce large quantities of pro
teins at relatively loW cost, for example, to produce a thera
peutic polypeptide. A polypeptide can be puri?ed from the
plant and used for therapeutic or other purposes. In addition,
expression of a heterologous polypeptide such as an antigen
can provide a plant or plant-derived product containing the
antigen, Which can provide a potential loW cost oral vaccine

containing an appropriate antigen.
Another important application of plant viral vector systems

shoWs particular changes in codons, it is understood that one
skilled in the art can choose other codons that encode the
same amino acid, if desired.

sequence encoding the heterologous polypeptide betWeen the
?rst and second QM cleavage sites. Other BPMV vectors, as
disclosed herein, can also be used in a method for expressing
a heterologous polypeptide in a plant such as soybean. Such a
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is in studies on host gene function. With more plant genomic

information available, a high throughput tool is required.
Virus-induced gene silencing (VIGS) is an exceptional
reverse genetics tool that can be employed to generate mutant
60

phenotypes for conveying function to unknoWn genes. VIGS
has many advantages over other methods, for example, it is

quick and does not require plant transformation (Burch
Smith et al., 2004). In VIGS systems, viruses are designed to
carry partial sequence of knoWn or candidate genes in order to
65

link their function to the mutant phenotype. Replication of the
recombinant virus and generation of dsRNA intermediates

trigger the RNA-mediated host defense system, resulting in
degradation of RNA With sequence identity to the recombi

US 7,618,815 B2
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nant virus including mRNA of the gene of interest. The tar
gets of VIGS can be a single gene, several members of a gene
family, or several distinct genes (Lu et al., EMBO J. 22,

on soybean (Anjos et al., Phytopathology 82:1022-1027
(1992)). Furthermore, soybean is not a natural host for

5690-5699 (2003a); Peele, et al., PlantJ. 27:357-366 (2001);
Tumage, et al.,. Plant J. 30:107- 117 (2002)). Many model
host plants including N. benthamiana, tomato, tobacco, Ara
bidopsis, and cassava have been explored (Burch-Smith, et

United States (Lomonossoff, Encyclopedia of Wralogy, 2nd

CPMV, and the virus is not believed to be present in the

ed pp. 285-291 (1999)). Thus, CPMV-based vectors cannot
be released in the ?eld in the US. or other countries Where

CPMV is not endemic for practical applications. The insta

al., PlantJ. 39:734- 746 (2004)). With the current abundance
of genomic information on soybean and model legume spe

bility of the CPMV-RNA2 vector appears to be related to
homologous recombination, Which may occur as a conse

quence of duplication of the cleavage sites that border the

cies (Stacey, et al., Plant Physiol. 135:59-70 (2004)), it is
timely to apply VIGS to soybean to enhance knowledge of

inserted foreign protein. In engineering the BPMV-RNA2

The invention additionally provides a method for virus
induced gene silencing in a soybean plant and vectors useful

vector disclosed herein, the nucleotide sequence of the dupli
cated regions Were altered based on degeneracy of the genetic
code Without affecting amino acid sequence in order to mini
miZe the chances of homologous recombination.
The level of foreign gene expression, as exempli?ed by the

in a method for virus-induced gene silencing. Such a method

BPMV-GFP vector, Was estimated to account for 1% of total

can include the step of inoculating a soybean plant With Bean
pod mottle virus (BPMV) RNA, Wherein the BPMV RNA
comprises a nucleic acid sequence encoding at least a portion
of a gene endogenous to the soybean plant. For virus-induced
gene silencing, a partial or entire sequence of an endogenous
gene can also be located in the untranslated regions (UTRs) of
RNA2, or in RNA1 if the sequence is small enough to be
accommodated, as discussed above, since it is the expression
of the nucleic acid encoding at least a portion of an endog

soluble proteins (see Example III). This level is comparable to
that reported for the PVX-based vectors (Culver, Wrology
226:228-235 (1996)).

gene function in such a major legume crop. As disclosed
herein, BPMV vectors of the invention can be used as a VIGS

vector for studies on gene function in soybean.

20

Soybean is the top oilseed crop in the World and provides an

extremely valuable, multi-billion dollar, source of high qual
25

date proteins With antifungal or insecticidal activities as Well
as other valuable proteins that may enhance the commercial

enous gene that results in gene silencing. For a virus-induced
gene silencing vector, the insertion in the UTRs can be facili

tated by engineering appropriate restriction sites for insertion
of the endogenous gene, so long as the inserted endogenous
sequence does not impair viral RNA replication and a su?i
cient amount of infective BPMV is produced.
As used herein, the term “endogenous,” When used in ref

value of soybean. The potential advantages that make BPMV
30

frame (ORF). In another embodiment, RNA2 polyprotein

an attractive vector system are that the virus (including mild

strains) multiplies to high levels in soybean (20-50 mg virus
from 100 g leaf tissue) and that it is stable and easily puri?ed.
For inoculation purposes under greenhouse conditions, puri
?ed recombinant BPMV virions or extracts from fresh or

erence to a polypeptide, nucleic acid or gene, refers to a

polypeptide, nucleic acid or gene that is expressed by a host.
For example, using a BPMV vector of the invention for a
method of virus-induced gene silencing, a BPMV vector is
engineered to express at least a portion of a gene endogenous
to the host plant such as soybean. In such a case, the endog
enous gene is already expressed in the host plant.
In one embodiment, the method for viral-induced gene
silencing can be performed With a vector containing a nucleic
acid sequence encoding at least a portion of an endogenous
gene that is encoded by an RNA2 polyprotein open reading

ity protein. It is highly desirable to increase the level of
soybean resistance to environmental stress, targeted pests,
and diseases in commercial varieties. The availability of the
BPMV expression vector alloWs rapid evaluation of candi

35

dried leaves from plants previously infected With the recom
binant vector Were successfully used. Although agroinocula
tion via leaf in?ltration is knoWn to provide the most ef?cient
means for introducing cDNA-derived viral RNA into the

leaves of some plant species (Lu et al., Methods 301296-303
40

(2003b)), soybean leaves are dif?cult to in?ltrate, and no
alternative conventional methods are presently available for

soybean agroinoculation.
The BPMV-based vector is suitable for use as a VIGS

vector to study gene function in soybean. The bleached
45

silencing phenotype of soybean plants inoculated With
BPMV vector carrying a fragment of the soybean PDS gene

ORF can comprise a ?rst and second protease cleavage site
such as a QM cleavage site, Wherein the nucleic acid

Was stable over time as it continued to develop throughout the

sequences encoding the ?rst and second protease cleavage
sites such as QM cleavage sites differ suf?ciently to reduce
homologous recombination betWeen the protease cleavage

has proved to provide an impressive means to study gene
function and has also been demonstrated to be particularly

duration of the experiment (35 dpi)(see Example VI). VIGS
50

useful in plants With genetic redundancy like soybean

site encoding nucleic acid sequences and Wherein the nucleic
acid sequence encoding at least a portion of an endogenous
gene is inserted betWeen the ?rst and second protease cleav
age sites such as QM cleavage sites, for example, betWeen the

movement protein (MP) and large coat protein (L-CP)

(LaWrence et al., Plant J. 36: 1 14-121 (2003)). The most
Widely used VIGS vectors are based on potato virus X (PVX)
or tobacco rattle virus (TRV) (Liu et al., PlantJ. 31 :777-786

encoded by the RNA2 polyprotein. Other vectors of the

(2002); Lu et al., EMBO J. 22:5690-5699 (2003a)), and their
applications have been mainly studied in N. benthamiana,

invention as disclosed herein can also be used in a method for

Where VIGS response is generally stronger and more endur

55

virus-induced gene silencing.

ing than in other plants (Lu et al., supra, 2003a). Recently,

The results disclosed herein represent the ?rst report to
demonstrate that BPMV-based vectors are suitable for e?i

e?icient VIGS systems have also been developed for a feW
60

cient expression of heterologous proteins in soybean. The
BPMV-RNA2 vector disclosed herein is the ?rst plant-virus
based vector described to date that is appropriate for expres

sion of foreign proteins in soybean. Although the CPMV
RNA2 vector (Gopinath et al., Wrology 267: 159-173 (2000))
could potentially be used as an expression vector in soybean,
it is unstable, and CPMV infection induces severe symptoms
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additional host plants including barley, tomato, and Pisum
sativum (Constantin et al., Plant J 40:622-631 (2004);
HolZberg et al., Plant J. 3011-13 (2002); Liu et al., Plant J.
31:777-786 (2002)). There is presently an urgent need for a
VIGS vector suitable for use in soybean considering the sub
stantial Wealth of available information on soybean genom
ics. None of the previously establishedVIGS vectors is appro

priate for use in soybean. Although full-length cDNA

US 7,618,815 B2
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infectious clones are available for the potyviruses SMV and

sible for differences in symptom severity betWeen mild and

Clover yellow vein virus that can infect soybean (Hajimorad
et al., l/irology 3141497-509 (2003); Masuta et al., Plant J.

severe strains Were identi?ed (Gu et al., l/irology 3331271
283 (2005)). Since BPMV RNA2 does not play a direct role in

231539-546 (2000)), neither has been evaluated as a VIGS

symptom severity and since it is the genomic segment that

vector. Potyviruses are unlikely to provide e?icient VIGS
vectors because they encode potent suppressors of RNA
silencing (HC-Pro proteins). HC-Pro has been shoWn to sup
press both VIGS and transgene-induced RNA silencing
(Anandalakshmi et al., Proc. Natl. Acad. Sci. USA.
95113079-13084 (1998); Roth et al., Virus Res. 102197-108

carries the foreign gene of interest, it is then a simple matter
to avoid interference from virus symptoms by using RNA1
derived from a mild strain (as demonstrated With the mild
strain K-Hal) or from a modi?ed RNA1 engineered to cause

attenuated symptoms combined With enhanced production of
the recombinant RNA2.

Although exempli?ed herein With soybean, it is understood

(2004)).
The results disclosed herein With the recombinant BPMV
PDS indicate that the BPMV-based VIGS vector induced

that a BPMV vector of the inventions can be used in other

e?icient and reliable gene silencing in soybean (see Example
VI). This represents the ?rst report providing experimental
evidence that the RNA silencing machinery is operational in
soybean. RNA silencing (also knoWn as posttranscriptional
gene silencing or PTGS) is implicated in the synergistic inter

BPMV. For example, other cultivars of bean and leguminous

action betWeen BPMV and SMV in dually infected soybean
plants that results in enhanced symptom severity and accu
mulation of BPMV (Anjos et al., Phylopalhology 8211022
1027 (1992)). This synergy is caused by SMV HC-Pro-me
diated suppression of RNA silencing, as Was clearly
demonstrated by inoculation of soybean With the recombi
nant BPMV-HC-Pro construct, as disclosed herein. BPMV

suitable host plant organisms that support the propagation of
Weeds are also knoWn to be hosts for BPMV (Geisler et al.,
Plant Dis. 8611280-1289 (2002)). Therefore, the vectors of
the invention can be used in methods in other suitable host

plants as With soybean.
It is understood that modi?cations Which do not substan
20

tially affect the activity the various embodiments of this
invention are also provided Within the de?nition of the inven

tion provided herein. Accordingly, the folloWing examples
are intended to illustrate but not limit the present invention.
25

EXAMPLE 1

does not appear to code for any suppressors of RNA silencing.
In a recent study, using an A grobacZerium-mediated transient

Methods for Generation and Analysis of BPMV

expression system, suppression of GFP-RNA silencing in

Vectors

transgenic N. benlhamiana in?ltrated With any of the recom

binant agrobacteria carrying BPMV coding regions for the
primary or secondary polyprotein precursors or for any of the
individual mature proteins Was demonstrated (Gu and
Ghabrial, supra, 2005). In apparent contrast, the small coat
protein (S-CP) of the related CPMV Was reported to function
as a Weak suppressor of amplicon-induced silencing in N.

30

previously described, and their complete nucleotides
35

benlhamiana (Liu et al., supra, 2004). Similar experiments
benlhamiana. Assuming that BPMV S-CP, like that of
40

system of soybean, as judged by the results of the BPMV-PDS
experiments. Therefore, in a method for viral-induced gene
silencing, RNA silencing suppressors can optionally be
included, as discussed above and described in Example VI.
The inclusion of RNA silencing suppressors can enhance the
gene silencing and effects seen from the gene silencing.
There are presently available more than 300,000 expressed
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available genes and gene sequences that can potentially pro
vide valuable insight into structure and function of this model
crop legume. VIGS presents an ideal tool for large-scale
functional genomics to convert the soybean sequence infor
mation into functional information. The results disclosed
herein indicate that the BPMV-based vector is suited for this

purpose. A possible disadvantage of VIGS is that symptoms
induced by virus infection may obscure the phenotype asso

(version dated Apr. 28, 1993, Which is incorporated herein by
reference); K-Hal, RNA1, accession No. AF394606 (version
dated Feb. 25, 2005, Which is incorporated herein by refer
ence), RNA2, accession No. AF394607 (version dated Feb.
25, 2005, Which is incorporated herein by reference); K-Ho 1,
RNA1, accession No. AF394608 (version dated Feb. 25,
2005, Which is incorporated herein by reference), RNA2,
accession No.AF394609 (version dated Feb. 25, 2005, Which
sues Were used for virion puri?cation as previously described

(Ghabrial et al., Plant Dis. Rep. 611690-694 (1977)). Soybean
50

mosaic virus (SMV) strains G6 and G7 Were used for ampli

?cation of the HC-Pro coding regions. SMV strain designa
tion Was based on the differential reactions of soybean culti

vars carrying resistance genes to SMV (Cho and Goodman,
55

Phylopalhology 691467-470 (1979); GunduZ et al., Phylopa
zhology 941687-692 (2004)).
RNA extraction and Northern hybridization analysis. Viral
RNA Was isolated from puri?ed virions by the sodium dode

cyl sulfate (SDS)-phenol method (Peden and Symons, Vll’Ol
ogy 1551487-492 (1973)). Total RNA Was extracted from
60

ciated With silencing of the gene of interest. This should not
be a problem With the BPMV-soybean system based on cur

plant tissue using a hot phenol method (VerWoerd et al.,
Nucleic Acids Res. 1712362 (1989)). For Northern blot
hybridization analysis, the RNA samples Were denatured in

the presence of glyoxal and dimethyl sulfoxide and separated

rent knowledge of symptom severity determinants in BPMV.

by electrophoresis on a 0.8% agarose gel in 10 mM sodium

BPMV-induced symptom severity has recently been mapped
to RNA1 and more speci?cally to the coding regions of the
protease cofactor and the C-terrninal half of the putative heli
case. Furthermore, the amino acid positions that are respon

The nucleotide sequences are available at GenBank: K-G7,

is incorporated herein by reference). The BPMV strains Were
propagated in the soybean cultivar “Essex”, and infected tis

sequence tags (ESTs) that are derived from over 80 different
cDNA libraries representing a Wide range of soybean organs,

developmental stages, genotypes, and environmental condi
tions (Stacey et al., Plant Physiol. 135159-70 (2004)). This
soybean EST collection provides a large resource of publicly

sequences have been reported (Gu et al., Phylopalhology
921446-452 (2002); Gu and Ghabrial, I/irology 3331271-283
(2005), each of Which is incorporated herein by reference).
accession No. U70866 (version dated Mar. 16, 2001, Which is
incorporated herein by referenc) and accession No. M62738

cannot be carried out With BPMV because it does not infectN.

CPMV, functions as a Weak suppressor of RNA silencing,
such activity has little or no effect on the RNA silencing

Virus strains. BPMV strains KY-Hopkins 1 (K-Hol), KY
Hancock 1 (K-Hal), and KY-Graves 7 (K-G7) have been
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phosphate buffer, pH 6.3 (Sambrook and Russell, Molecular
Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor
Laboratory Press, NeW York (2001)). RNA Was transferred

onto Hybond-N+ membranes, (Amersham, PiscataWay,

US 7,618,815 B2
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N.J.), a positively charged nylon membrane With a binding
capacity for nucleic acids, according to the manufacturer’s

TABLE

instructions. The membranes Were then prehybridiZed,

1 — cont inued

List of primers used to construct BPMV vectors .

hybridized, and air-dried as previously described (Gu et al.,
supra, 2002). Full-length RNAl and RNA2 cDNA clones of

AatII-For-RZ

GGACGTCGAGACTCCAAAAGGTTCCAT

(SEQ ID NO: 4)

strain K-G7 (strain subgroup I) or K-Hal (strain subgroup 11)
Were used as templates for probe preparation by the

SwaI-Rev-RZ

REDIPRIME 11 random prime labeling system (Amersham),

AATTTAAATAGATTTGTTTCCATTTGAGC

(SEQ ID NO: 5)

a DNA labeling system, according to the manufacturer’s
GFP-For

instructions. The Northern blots Were exposed to a phospho
rimager screen, and the images Were visualiZed With a PHOS

AATTTAAATTGTCTCTTGATGATGTTGAAACACCCAA
AGGATCAATGAGTAAAGGAGAAGAACTTTTCACT

(SEQ ID NO: 6)

PHORIMAGER 445 S1 system and analyZed With the

IMAGEQUANT 4.1 software program (Amersham).

GFP-Rev

Construction of BPMV RNA2 vectors. Full-length infec

tious BPMV RNA2 cDNA clones (pGG7R2 and pGHoR2),
derived from subgroup I and 11 strains, respectively, Were

(SEQ ID NO: 7)
RFP-For

used for construction of the BPMV RNA2 vectors. Unless

otherWise speci?ed, transcripts derived from plasmid
pGHoRl containing a full-length infectious RNAl cDNA
(type I, RNAl) Were used along With transcripts from recom
binant plasmids derived from pGG7R2 or pGHoR2 in all

20

RFP-Rev

VecModi-Forl

AATTTAAATTGTCTCTTGATGATGTTGAAACACCC

(SEQ ID NO: 10)

25
VecModi-Revl

and the PCR products Were cloned into the pGEM-T easy
vector (Promega, Madison, Wis.). The resultant clones Were

TTGGCCAGGATCCTTTGGGTGTTTCAACATCATC

(SEQ ID NO: 11)
VecModi-For2

ATCGATGGCCACAATATAACGAGGTGCAAGCCCAAAT
GGAGACC

30

(SEQ ID NO: 12)
VecModi-RevZ

GACGTCGTCCAATGAAAGCTTAAACAAGTTGGTCTCC
ATTTGGG

ended, and self-ligated to remove the Aatll restriction site in

(SEQ ID NO: 13)

the vector and to create the neW constructs pGG7R2-2 and

pGHoR2-2. The GFPS gene Was ampli?ed using plasmid
pZGFP (Soldevila and Ghabrial, J. l/zrol. 74:997-1003
(2000)) as a template and the primer pair GFP-For and GFP
Rev (Table 1). The PCR product Was cloned into the pGEM-T

GACGTCGTCCAATGAAAGCTTAAACAAGTTAGTCTCC
ATTTGTGCTTGCACCTCGTTATATTGGGCGCCGGTGG
AGTGG

(SEQ ID NO: 9)

GFP constructs. The 5'-half of BPMV RNA2 cDNA in

digested With SWal and Ncol, and tWo clones, pGG7R2-1 and
pGHoR2-1, Were selected folloWing veri?cation by restric
tion enZyme digestion and nucleotide sequencing. Clones
pGG7R2-1 and pGHoR2-1 Were digested With Aatll, blunt

ATTTAAATTGTCTCTTGATGATGTTGAAACACCCAAA
GGATCAATGGCATCCTCTGAAGATGTTATCAAG

(SEQ ID NO: 8)

inoculations. Plasmids pGHoRl, pGG7R2, and pGHoR2
Were described previously (Gu and Ghabrial, supra, 2005).

plasmids pGG7R2 or pGHoR2 (1830 bp) Was ampli?ed by
PCR using the primer pair F1 and SWal-Rev-R2 (Table 1),

GGACGTCGTCCAATGAAAGCTTAAACAAGTTAGTCTC
CATTTGTGCTTGCACCTCGTTATATTGTTTGTATAGT
TCATCCATGCCATGTG

35

SMV-Af

GGATCCTCCCAAAATCCTGAAGCTCAGTT

(SEQ ID NO: 14)
SMV-Ar

ACTGTCAAAGATCCAAAAGAGTC

(SEQ ID NO: 15)

easy vector, and the resultant clone (pGGFP-l) Was veri?ed

by sequencing. The pGG7R2-2 and pGHoR2-2 constructs

40 SMV-Bf

in plasmids pGG7R2 or pGHoR2 (1841 bp) Was ampli?ed by
PCR using the primerpairAatll-For-R2 and R1 (Table 1), and

SMV-Br

TCATCCTCTGTTGCACGATATCACCAACTCT

(SEQ ID NO: 17)
TEV- P2 - For

45

the PCR products Were cloned into the pGEM-T easy vector
to generate clones pGG7R2-4 and pGHoR2-4, Which Were

GGATCCAGCGACAAATCAATCTCTGAGGCA

(SEQ ID NO: 18)
TEV- P2 —Rev

veri?ed by sequencing. Clones pGG7R2-4 and pGHoR2-4

GATATCTCCAACATTGTAAGTTTTCATTTCGGA

(SEQ ID NO: 19)

Were digested With Sacl and Pstl, blunt-ended, and self-li
gated to remove the vector Sall site and to generate clones

GACTCTTTTGGATCTTTGACAGT

(SEQ ID NO: 16)

Were digested With SWal and Sall and ligated into similarly
digested pGGFP-l to generate constructs pGG7R2-3 and
pGHoR2-3, respectively. The 3'-half of BPMV RNA2 cDNA

TB SV - P 1 9 - For

50

CGCGGATCCATGGAACGAGCTATACAAGGA

(SEQ ID NO: 20)

pGG7R2-5 and pGHoR2-5, respectively. Finally, clones
TBSV-PlQ-Rev

pGG7R2-5 and pGHoR2-5 Were digested WithAatll and Sall
and the resultant smaller fragments Were isolated and ligated

(SEQ ID NO: 21)

into Aatll/Salldigested pGG7R2-3 and pGHoR2-3, respec
tively, to produce the infectious constructs pGG7R2-GFP and

TGTGTTGGCCACTCGCTTTCTTTTTCGAAGGT

TCV-CP-For

CGCGGATCCATGGAAAATGATCCTAGAGTC

(SEQ ID NO: 22)
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pGHoR2-GFP.
TCV-CP-Rev

TABLE 1

ATTGGATATCAATCCTGAGTGCTTGCCATTTTCC

(SEQ ID NO: 23)
PDS-For

List of primers used to construct BPMV vectors .

CCGCGGATCCGCCGCTTGTGGCTATATATCT

(SEQ ID NO: 24)
Fl

TAATACGACTCACTATAGTATTAAAATTTTCATAAGA
TTTGAAATTTTGATAAACCG

PDS-Rev

(SEQ ID NO: 2)
RI

(SEQ ID NO: 25)

TTCCGCGGCCGCTATGGCCGACGTCGACTTTTTTTTT
TTTTTTTTT

(SEQ ID NO: 3)

CACAGATATCTCCTGCACCGGCAATAACGAT
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DsRed constructs. The DsRed gene Was ampli?ed by PCR

using plasmid pDsRed2-C1 (Clontech, Palo Alto Calif.), as a
template, and primers RFP-For and RFP-Rev (Table 1). The
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15

16

PCR product Was cloned into the pGEM-T easy vector to

site in the SMV-HC-Pro coding region Without changing the

generate clone pGdsRed-1, Which Was con?rmed by
sequencing. The DsRed gene Was released from pGdsRed-1
by digestion With SWaI and AatII, and the resultant fragment

the ?rst step, tWo overlapping cDNA fragments containing

amino acid sequence, a tWo-step PCR method Was used. In

the entire HC-Pro sequence (fragments A and B covering the
5' and 3' halves, respectively) Were PCR-ampli?ed in separate
reactions using ?rst strand cDNA as a template and tWo pairs
of primers (SMV-Ar and SMV-Af and SMV-Br and SMV
Bf). The reverse primer of fragment A (SMV-Ar; 23 nucle
otides in length) is complementary to the forWard primer of

Was ligated into plasmids pGG7R2-GFP and pGHoR2-GFP,
Which Were SWaI/AatII-digested, to replace the GFP gene and
generate the infectious constructs pGG7R2-DsRed and

pGHoR2-DsRed, respectively.
Vector modi?cation. To generate a suitable BPMV-RNA2

vector for cloning and expression of foreign genes, the GFP

fragment B (SMV-Bf). Equimolar amounts of each fragment

construct, pGG7R2-GFP (FIG. 1), Was modi?ed to remove

along With primers SMV-Br and SMV-Af Were used for the
second step PCR. The ?nal PCR product Was cloned into the
pGEM-T easy vector, and clones in the correct orientations
Were con?rmed by sequencing. The inserted HCPro genes
from strains G6 and G7 Were digested With BamHI and

most of the GFP sequences and to insert tWo neW restriction
sites. To introduce a BamHI restriction site into the BPMV

RNA2 vector, primers VecModi-Forl and VecModi-Revl,
Which partially anneal to each other, Were subjected for PCR,
and the product Was cloned into the pGEM-T easy vector and

EcoRV and ligated into BamHI/MscI-digested pGG7R2 -V to

con?rmed by sequencing (pVec-Modi-l). A similar approach

produce pGG7R2-HCPro(S6) and pGG7R2-HCPro(S7),

Was used to introduce a second MscI restriction site into the

respectively.

BPMV RNA2 vector; primers VecModi-For2 and VecModi
Rev2 (Table 1), Which partially anneal to each other, Were
subjected to PCR, and the product Was cloned into the

Phytoene desaturase (PDS) constructs. Soybean genomic
20

DNA Was extracted from leaves of the soybean cultivar

25

‘Essex,’ as previously described (Srinivasa et al., Phylopa
Zhology 91:831-838 (2001)). A 318 bp PDS fragment Was
PCR-ampli?ed using the primer pair PDS-sen5 -For and PDS
sen5-Rev (Table 1). The PCR product Was digested With
BamHI and EcoRV and ligated into BamHI/MscI-digested
pGG7R2-V to generate construct pGG7R2-PDS.
Nucleotide sequencing. All sequencing Was done using the
BIGDYE Terminator DNA Sequencing Kit (Applied Biosys
tems, Foster City Calif. USA) and the ABI Prism 310 genetic

pGEM-T easy vector and con?rmed by sequencing (pVec
Modi-2). Plasmid pGG7R2-GFP Was digested With SWaI and
MscI, and the resultant larger fragment Was isolated and

ligated into similarly digested pVecModi-2 to generate plas
mid pGG7R2-6. The latter Was then digested With ClaI and
AatII, and the resultant larger fragment Was isolated and

ligated into similarly digested pVecModi-l to generate the
BPMV-RNA2 vector, designated pGG7R2-V (FIG. 1).
Bar constructs. The bar gene (coding for phosphinothricin
acetyltransferase) Was released from plasmid pBG-GD

30

(Straubinger et al., Fungal Genet. Newsl. 39: 82-83 (1 992)) by
digestion With BglII, blunt-ended With KlenoW large frag
ment DNA polymerase (Invitrogen, Carlsbad Calif.), and
then digested With BamHI. The DNA fragment containing the
bar gene Was gel-puri?ed and ligated into pGG7R2-V, previ

Inc., Frederick, Md., USA).
In vitro transcription and inoculation. Plasmids pGHoRl
(containing full-length cDNA clone to type I RNA1, from
35

for in vitro transcription as previously described (Gu and

Ghabrial, supra, 2005). After transcription, 5 pl samples of

Constructs of RNA silencing suppressors. TBSV P19 gene

Was ampli?ed from plasmid PZPTBSVp19 (Qu et al., .1. Virol.

the reaction mixture Were analyZed on a 1% agarose gel to
40

late fully expanded primary soybean leaves by rub inocula
tion.

Protein expression and Western blot analysis. Total protein

and the released P19 gene Was cloned into BamHI/Mscl
45

extraction from soybean leaves Was performed as described

by Osherov and May (Fungal Genet. Newsl. 45:38-40

crinkle virus (TCV) coat protein (CP) gene Was ampli?ed

from plasmid PZP-TCVCP (Qu et al., supra, 2003) using
primers TCV-CP-For and TCV-CP-Rev (Table 1), and the

(1998)). Protein concentration Was estimated by the Bio-Rad

protein assay method (Bio-Rad Laboratories, Hercules
Calif.). A knoWn amount of puri?ed, bacterially expressed,

resultant PCR product Was cloned into the pGEM-T easy
vector. Clones in the correct orientation Were selected and

assess yield and quality of the transcripts. RNA transcripts (a
mixture of RNA1 and RNA2 transcripts) Were used to inocu

cloned into the pGEM-T easy vector. Clones in the correct
orientation Were selected and digested With BamHI and MscI,

digested pGG7R2-V to produce pGG7R2-P 19. Turnip

strain K-Hol) and pCRHaRl (containing full-length cDNA
to type II RNA1, from strain K-Hal) Were used as templates

ously digested MscI and BamHI, to produce pGG7R2-Bar.
77:511-522 (2003)) using the primer pair TBSV-P19-For and
TBSV-P19-Rev (Table 1), and the resulting PCR product Was

analyZer. Sequence analysis Was performed using the DNA
strider (CEA, France) and Vector NTI programs (Informax

50

GFP Was used as a standard in assays to assess expression

digested With BamHI and EcoRV, and the released CP gene
Was cloned into BamHI/MscI-digested pGG7R2-V to pro

levels of recombinant GFP. For this purpose, the Wild-type
GFP gene Was released from plasmid pIVEX2.3 (Roche

duce pGG7R2-TCP. The coding region of Tobacco etch virus
(TEV) HC-Pro Was ampli?ed by PCR using plasmid

Applied Science, Indianapolis, Ind., USA) by digestion With

pTEV7D, Which contains a full-length cDNA of TEV-RNA
(Dolja et al., Proc. Natl. Acad. Sci. USA. 89:10208-10212
(1992)), as a template along With primers TEV-P2-For and
TEV-P2-Rev (Table 1). The resultant PCR product Was
cloned into the pGEM-T easy vector, and clones in the correct
orientation Were digested With BamHI and EcoRV. The

XbaI and BamHI and cloned into pET21d vector (EMD Bio
55

sciences, San Diego, Calif., USA). The resulting clone Was
transformed into E. coli strain BL21 (DB3), and GFP expres
sion Was induced and puri?ed according to manufacturer’s

instructions (EMD Biosciences). Western blot analysis Was

released HC-Pro gene Was then cloned into BamHI/Mscl

carried out as previously described (Srinivasa et al., supra,
2001) using antisera to BPMV CP and GFP (Chemicon Inter
national Inc., Temecula, Calif.). GFP expression level Was

digested pGG7R2-V to produce pGG7R2-HCPro(T). An RT

assessed using IMAGEQUANT v5.2 (Amersham).

PCR approach Was used to clone SMV HC-Pro coding
region. A reverse primer (SMVBr; Table 1) Was used for ?rst

Fluorescence detection. Whole leaf green ?uorescence
images Were acquired using BioChemi-V cooler camera
mounted on Epi Chemi II Darkroom (UVP company, Upland,

strand cDNA synthesis With total RNA from soybean leaves

60

65

infected With SMV strains G6 or G7 and a SUPERSCRIPT II

Calif., USA). The settings Were overhead excitation light 365

reverse transcription kit (Invitrogen). To eliminate a BamHI

nm and ?lter set as SYBR Green (Hoechst Blue). The Lab

US 7,618,815 B2
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Works Ver 4.0.0.8. software Was used for acquiring images,

em blot analysis (FIG. 3). A?inity-puri?ed His-tagged GFP,

Which Were exported as TIFF ?les.

Which Was expressed in E. coli, Was used as a control (FIG. 3,

lane 7). Interestingly, the expression level provided by sub

Herbicide treatment. One-Week-old soybean seedlings

group I RNA2 vectors Was higher than that obtained With
subgroup II RNA2 vectors in both the ?rst and second trifo

Were inoculated With the recombinant BPMV-bar construct.

TWo Weeks later, the infected soybean plants Were sprayed
With the herbicide Liberty, Which contains glufosinate-am
monium (GA) as the active ingredient (Aventis CropScience,

liolate leaves (compare lanes 3 and 5, FIG. 3). To assess the
GFP expression level, the Western blot Was scanned, and the

Research Triangle Park, NC), at a concentration of 0. 1 % GA

generated images of band intensity Were analyZed by the

(W/v) in deioniZed Water. The soybean plants Were photo

ImageQuantTM v5.2 program (Amersham). The results indi

graphed 3 Weeks after herbicide treatment.

cated that GFP expression level can account for as much as

approximately 1% of total proteins in soybean.
EXAMPLE II
EXAMPLE IV

Construction of BPMV RNA2 Vectors

Stability of the Foreign Gene Expressed from BPMV
RNA2 Vectors

For development of BPMV as a viral vector for expression

of heterologous proteins in soybean, the gene of interest Was
inserted into the RNA2-encoded polyprotein ORF betWeen
the MP and the L-CP coding regions. Additional proteinase
cleavage sites Were created to ?ank the foreign protein by

20

duplicating the MP-LCP cleavage site (as exempli?ed by the
GFP gene construct in FIG. 1A). The coding sequences for
the 8 C-terminal amino acids of the MP and the 19 N-terminal
amino acids of the L-CP Were included for ef?cient process

ing. To minimiZe the chances of homologous recombination,

To assess the stability of inserted foreign genes during
serial plant passages, virions Were puri?ed from soybean
plants previously infected With the BPMV-GFP or BPMV
DsRed constructs. FolloWing three passages of the recombi
nant BPMV vector, viral RNA Was isolated from puri?ed

25

virions and subjected to Northern hybridiZation analysis
(FIG. 4). Only a single band of the predicted siZe of the
recombinant RNA2 containing the coding sequences for GFP

thus instability, the third nucleotide in each codon Was

or DsRed Was resolved. No Wild-type RNA2 Was detected

changed based on codon degeneracy (in accordance With

even folloWing extended overexposure of the blots. Further

BPMV codon usage) so that the encoded amino acid residues

more, ?uorescence due to expression of GFP or DsRed Was

remained unchanged (FIG. 1A). Initially, BPMV recombi

readily detected in the seed coats from immature seeds, sug
gesting that the foreign genes Were stably expressed at a later

nant vectors expressing GFP or DsRed Were constructed and

30

developmental stage during pod formation.

shoWn to be infectious and stable. Under greenhouse condi
tions, the GFP construct Was passaged 4 times Without any

As disclosed herein, the BPMV-GFP vector Was stable
after four serial passages in soybean, and no traces of Wild

apparent reduction in ?uorescence intensity (FIG. 2).
The BPMV vector Was further modi?ed to include addi

tional cloning sites (FIG. 1B); foreign genes can be cloned by
digesting the vector pGG7R2-V With BamHI and MscI (for
directional cloning) or by digestion With MscI (for blunt end
cloning). TWo sets of BPMV RNA2 vectors corresponding to
BPMV RNA2 subgroups I and II Were constructed.
Several different genes that varied in siZe and biological
activity Were cloned into the BPMV RNA2 vectors utiliZing
the BamHI and MscI restriction sites in the modi?ed vector

35

maintained throughout the soybean plant including the seed

40

Dis. 86:1280-1289 (2002)). Because BPMV does not infect
N. benlhamiana or tobacco, Which are knoWn to support the
45

resistance bar gene (coding for phosphinothricin acetyltrans
ferase) and several viral-encoded suppressors of host-medi
ated RNA silencing. These included the P-19 and coat protein

coats of immature seeds provides further evidence for the
endured stability of the GFP construct. The BPMV-GFP vec
tor Was also stable after three serial passages in Phaseolus
vulgaris cv. Black Velvet. In addition to soybean and a feW
cultivars of bean, the host range of BPMV is very limited and

includes only some leguminous Weeds (Giesler, et al., Plant

(FIG. 1B). In all cases, the foreign protein Was placed
betWeen tWo arti?cial cleavage sites With duplication of 27
virus-derived amino acids, for ef?cient processing, as
described for the GFP constructs. These genes ranged in siZe
from 520 bp to 1400 bp (FIG. 1C) and included the herbicide

type virus Were detected by Northern hybridiZation analysis
(FIG. 4). The ?nding that the bright green ?uorescence Was

50

(CP) encoded by Tomato bushy stunt virus (TBSV) and Tur
nip crinkle virus (TCV), respectively, and the helper compo
nent-protease (HCPro) encoded by Soybean mosaic virus
(SMV) and Tobacco etch virus (TEV).

ampli?cation and foreign gene expression of most estab
lished plant viral vectors, it is not possible to compare the
BPMV-based vectors With others in regard to insert instabil
ity. It is knoWn that ho st factors affect viral RNA replication
and recombination and may thus contribute to reported dif
ferences in the frequencies of viral RNA recombination
among diverse host species (Ahlquist, et al., J. l/zrol. 7718181

8186 (2003); Desvoyes, et al., Wrology 304:434- 442 (2002);
DZianott, et al., Wrology 318:482-492 (2004)). It is possible

EXAMPLE III

that host factors in soybean play a role in the stability of the
BPMV-based vectors by suppressing viral RNA recombina
tion.

Expression Levels of Foreign Genes from BPMV

EXAMPLE V

55

Vectors
60

Biological Activity of Gene Products Expressed
from BPMV RNA2 Vectors

The recombinant BPMV-GFP constructs Were used to

evaluate foreign gene expression levels in soybean. The pri
mary leaves of 7- to 10-day-old soybean seedlings Were
inoculated With the BPMV-GFP constructs derived from
either subgroup I or subgroup II BPMV RNA2. Three Weeks

postinoculation, total soluble proteins Were extracted from
the ?rst and second trifoliolate leaves and subjected to West

Plants infected With the BPMV-bar construct Were resistant
to ammoniumglufosinate When applied as a 0.1 % solution
65

(W/v) in deioniZed Water (FIG. 5A). In contrast, the nonin
oculated control, BPMV K-G7-infected plants, and plants
infected With the BPMV-GFP construct Were killed Within 3

US 7,618,815 B2
19

20

Weeks after herbicide treatment (FIG. 5). Furthermore, plants

Were prepared from the upper leaves and used to inoculate a

second set of healthy soybean seedlings. Representative

infected With BPMV-bar construct Were found to Withstand
ammonium glufosinate treatment at a concentration of 1%

upper leaves harvested at 21 dpi from the second passage
plants are shoWn in FIG. 7. VIGS of the PDS gene Was clearly
evident regardless of the source of RNA1 (Whether from the
mild strain K-Hal or the severe strain K-Hol) or the soybean

(W/v) in deionized Water With little or no damage.

It is knoWn that certain RNA silencing suppressors

encoded by plant viruses may enhance symptom severity
induced by heterologous viruses (Pruss et al., Plant Cells
9:859-868 (1997); Yang and Ravelonandro, Arch. l/zrol. 147:

cultivar used, Essex, Clark, Williams, or York.
Expression of RNA silencing suppressors from recombi

2301-2312 (2002)). Three different viral RNA silencing sup

nant BPMV vectors shoWed signi?cant enhancement in

pressors (TBSV-P19, TCV-CP, SMV-HC-Pro) With appar
ently dissimilar underlying mechanisms (Roth et al., l/zrus

symptom severity (FIG. 6) and in the accumulation of the
viral coat proteins, as assessed by immunoblot analysis and
ELISA for soybean plants infected With the BPMV-HC-Pro
construct. The enhancement in symptom severity and BPMV
accumulation in soybean plants infected With BPMVHC-Pro
construct is reminiscent of dual infection of soybean With
BPMV and SMV (Anjos et al., Phylopalhology 82: 1022
1027 (1992)) and is consistent With the idea that BPMV does

Res. 102:97-108 (2004)) Were cloned into the BPMV vector

and tested for their activity in soybean. The resulting con
structs Were infectious, and the infected plants shoWed very

severe symptoms including extensive stunting, leaf deforma
tion, blistering, and veinal necrosis compared With the rela
tively mild mottling symptoms induced by infections involv
ing Wild-type BPMV RNA2 (FIG. 6). The severe symptoms
induced by these constructs are reminiscent of the top necro

sis syndrome induced by double infection of soybean plants

20

not effectively suppress RNA silencing (Gu, et al., Wrology
333:271-283 (2005)). Expression of RNA silencing suppres
sors in combination With recombinant BPMV vectors may be

With BPMV and SMV (Anjos et al., Phylopalhology

useful for enhancing foreign protein expression levels (Mal

82:1022-1027 (1992)).

lory, et al., Nat. Biotechnol 20:622-625 (2002);Voinnet, Plant
J. 33 : 949-956 (2003)). Although expression of more than one

EXAMPLE V1
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the additional duplicated cleavage sites. Thus, expression of
RNA silencing suppressors from co-infecting recombinant

Virus-induced gene silencing (VIGS) is an attractive tool
for studies of gene function. To determine Whether a VIGS

vector based on BPMV could be useful in silencing of endog
enous soybean genes, a 318 bp fragment of the phytoene

30

Throughout this application various publications have

carotenoid pigment production, Was inserted into the BPMV
vector, and the resulting construct Was used to infect soybean.

developed typical photobleached leaves 2 Weeks postinocu

BPMV vector is probably a better approach.

been referenced. The disclosures of these publications in their
entireties are hereby incorporated by reference in this appli

desaturase (PDS) gene, Which is necessary for production of
Soybean plants inoculated With the recombinant BPMV-PDS

product (suppressor plus the proteins of interest) from the
same BPMV vector is theoretically feasible (upper limit for
insert size is 2.4 kbp), stability might be a concern because of

Silencing of Phytoene Desaturase in Soybean

cation in order to more fully describe the state of the art to
35

Which this invention pertains. Although the invention has
been described With reference to the exampled provided

lation, indicating that the PDS gene had been silenced (FIG.

above, it should be understood that various modi?cations can

7a). The BPMVPDS vector Was stable When leaf extracts

be made Without departing from the spirit of the invention.

SEQUENCE LISTING

SEQ ID NO 1
LENGTH: 27
TYPE: PRT

ORGANISM: Artificial Sequence
FEATURE:

OTHER INFORMATION: Chemically synthesized
<400> SEQUENCE:

l

Gln Tyr Asn Glu Val Gln Ala Gln Met Glu Thr Asn Leu Phe Lys Leu
1

5

l0

15

Ser Leu Asp Asp Val Glu Thr Pro Lys Gly Ser
20

25

SEQ ID NO 2
LENGTH: 57
TYPE: DNA

ORGANISM: Artificial Sequence
FEATURE:

OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 2

taatacgact cactatagta ttaaaatttt cataagattt gaaattttga taaaccg

US 7,618,815 B2
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22
—cont inued

<2ll> LENGTH: 46
<2l2> TYPE: DNA

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 3

ttccgcggcc gctatggccg acgtcgactt tttttttttt tttttt

<2ll> LENGTH:

46

27

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 4

ggacgtcgag actccaaaag gttccat

<2ll> LENGTH:

29

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 5

aatttaaata gatttgtttc catttgagc

<2l2> TYPE:

29

DNA

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 6

aatttaaatt gtctcttgat gatgttgaaa cacccaaagg atcaatgagt aaaggagaag
aacttttcac t

<2ll> LENGTH:

90

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: '7

ggacgtcgtc caatgaaagc ttaaacaagt tagtctccat ttgtgcttgc acctcgttat
attgtttgta tagttcatcc atgccatgtg

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 8

atttaaattg tctcttgatg atgttgaaac acccaaagga tcaatggcat cctctgaaga

tgttatcaag

9O
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23
—cont inued

<2ll> LENGTH:

79

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: 9

gacgtcgtcc aatgaaagct taaacaagtt agtctccatt tgtgcttgca cctcgttata
ttgggcgccg gtggagtgg

79

<2lO> SEQ ID NO 10
<2ll> LENGTH: 35

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: lO
aatttaaatt gtctcttgat gatgttgaaa caccc

35

<2lO> SEQ ID NO 11
<2ll> LENGTH: 34

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: ll

ttggccagga tcctttgggt gtttcaacat catc

34

<2lO> SEQ ID NO 12
<2ll> LENGTH: 44

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: l2

atcgatggcc acaatataac gaggtgcaag cccaaatgga gacc

44

<2lO> SEQ ID NO 13
<2ll> LENGTH: 44

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: l3

gacgtcgtcc aatgaaagct taaacaagtt ggtctccatt tggg

44

<2lO> SEQ ID NO 14
<2ll> LENGTH: 29

<2l3> ORGANISM: Artificial Sequence
<220> FEATURE:

<223> OTHER INFORMATION: Primer chemically synthesized
<400> SEQUENCE: l4

ggatcctccc aaaatcctga agctcagtt
<2lO> SEQ ID NO 15
<2ll> LENGTH: 23
<2l2> TYPE: DNA

<2l3> ORGANISM: Artificial Sequence

29

